AU2018313164A1 - Method for treating Schnitzler's syndrome - Google Patents

Method for treating Schnitzler's syndrome Download PDF

Info

Publication number
AU2018313164A1
AU2018313164A1 AU2018313164A AU2018313164A AU2018313164A1 AU 2018313164 A1 AU2018313164 A1 AU 2018313164A1 AU 2018313164 A AU2018313164 A AU 2018313164A AU 2018313164 A AU2018313164 A AU 2018313164A AU 2018313164 A1 AU2018313164 A1 AU 2018313164A1
Authority
AU
Australia
Prior art keywords
syndrome
schnitzler
dapansutrile
day
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018313164A
Other languages
English (en)
Inventor
Charles A. Dinarello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olatec Therapeutics Inc
Original Assignee
Olatec Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olatec Therapeutics Inc filed Critical Olatec Therapeutics Inc
Publication of AU2018313164A1 publication Critical patent/AU2018313164A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2018313164A 2017-08-11 2018-08-08 Method for treating Schnitzler's syndrome Abandoned AU2018313164A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762544617P 2017-08-11 2017-08-11
US62/544,617 2017-08-11
PCT/US2018/045752 WO2019032672A1 (en) 2017-08-11 2018-08-08 METHOD OF TREATING SCHNITZLER SYNDROME

Publications (1)

Publication Number Publication Date
AU2018313164A1 true AU2018313164A1 (en) 2020-03-19

Family

ID=65271433

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018313164A Abandoned AU2018313164A1 (en) 2017-08-11 2018-08-08 Method for treating Schnitzler's syndrome

Country Status (5)

Country Link
US (1) US20200170990A1 (https=)
EP (1) EP3664786B1 (https=)
JP (1) JP2020530472A (https=)
AU (1) AU2018313164A1 (https=)
WO (1) WO2019032672A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4045009A4 (en) * 2019-10-14 2023-11-01 Olatec Therapeutics LLC METHOD FOR TREATING BREAST CANCER
US20230330054A1 (en) * 2020-03-31 2023-10-19 Olatec Therapeutics Llc Method for preventing or treating lung infection and lung inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2651407B1 (en) * 2010-12-15 2016-12-21 Olatec Industries LLC 3-methanesulfonylpropionitrile for treating inflammation and pain
EP2999691A4 (en) * 2013-05-21 2017-02-08 Virginia Commonwealth University Cryopyrin inhibitors for preventing and treating inflammation
US10195170B2 (en) * 2015-08-17 2019-02-05 Twi Biotechnology, Inc. Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs
US20170145412A1 (en) * 2015-11-04 2017-05-25 Idera Pharmaceuticals, Inc. Compositions for inhibiting nlrp3 gene expression and uses thereof
ES2970485T3 (es) * 2017-01-06 2024-05-29 Olatec Therapeutics Llc Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares

Also Published As

Publication number Publication date
EP3664786B1 (en) 2022-10-05
US20200170990A1 (en) 2020-06-04
EP3664786A4 (en) 2021-03-31
EP3664786A1 (en) 2020-06-17
WO2019032672A1 (en) 2019-02-14
JP2020530472A (ja) 2020-10-22

Similar Documents

Publication Publication Date Title
US11197821B2 (en) Formulations for treatment of dry eye disease
CN108884053B (zh) 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法
JP2009514889A (ja) 癌を治療するためにｓａｈａ及びボルテゾミブを用いる方法
US20200170990A1 (en) Method for treating schnitzler's syndrome
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
CN111867678B (zh) 治疗黑色素瘤的方法
JP2022551672A (ja) 乳癌治療法
CN102781238A (zh) Tivozanib和坦罗莫司的组合
US20240269104A1 (en) Method for treating parkinson's disease
EP3784243B1 (en) Methotrexate for use as a medicament
US20240122956A1 (en) Application of Naringin Combined with Rapamycin in Preparation of Medications for Treating Hyperlipidemia
US20240358669A1 (en) Methods for treating pancreatic cancer
CN110891580A (zh) 使用三氧化二砷治疗多发性硬化症的方法
JP2025516925A (ja) 再発がんを前治療する方法
WO2023202439A1 (zh) 二萜化合物衍生物或其盐在制备防治特应性皮炎的药物中的应用
WO2022226495A1 (en) Method for treating spinal cord injury
CN118986975A (zh) 一类新型ces2抑制剂在制备防治化疗相关副作用药物中的用途
HK1261918B (en) Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
BR112018012195B1 (pt) Uso de 2-[4-(1,1-dimetiletil)fenil]-1h-benzimidazol, ou um sal farmaceuticamente aceitável do mesmo
WO2016192098A1 (zh) 包含阿卡波糖之医药组合物及其用于免疫调节之用途

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period